Literature DB >> 19688180

Dendritic cells and macrophages in kidney disease.

Koichi Matsumoto1, Noboru Fukuda, Masanori Abe, Takayuki Fujita.   

Abstract

Recent studies on dendritic cells (DCs) and macrophages have greatly advanced our knowledge of glomerular immunopathology. This rapidly developing field most likely has considerable impact on our understanding of the major mediators of tissue injury and repair in kidney disease. The pivotal role of cytokine in the initiation, differentiation, and amplification of local immune response production by antigen-presenting cells (APC; DCs, macrophages, and so forth) has been well documented, but the precise biological role of the numerous APC-derived products as effectors in both renal inflammation and repair remains a topic of intense research. This review focuses on the activated DCs and macrophages for the development and resolution of kidney disease, and discusses mechanistic information on the inflammatory process, including tissue injury and healing. A multi-dimensional study may contribute to further clarification of the role of their cellular activation in the progression of human kidney disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19688180     DOI: 10.1007/s10157-009-0218-y

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  103 in total

Review 1.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

2.  Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions.

Authors:  A M Woltman; J W de Fijter; K Zuidwijk; A G Vlug; I M Bajema; S W van der Kooij; V van Ham; C van Kooten
Journal:  Kidney Int       Date:  2007-03-14       Impact factor: 10.612

3.  Macrophages transfected with adenovirus to express IL-4 reduce inflammation in experimental glomerulonephritis.

Authors:  D C Kluth; C V Ainslie; W P Pearce; S Finlay; D Clarke; I Anegon; A J Rees
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

4.  Inhibition of nuclear factor-kappaB activation reduces cortical tubulointerstitial injury in proteinuric rats.

Authors:  G K Rangan; Y Wang; Y C Tay; D C Harris
Journal:  Kidney Int       Date:  1999-07       Impact factor: 10.612

5.  Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors.

Authors:  M A Antonysamy; W C Fanslow; F Fu; W Li; S Qian; A B Troutt; A W Thomson
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

6.  Latent TGF-beta1 protects against crescentic glomerulonephritis.

Authors:  Xiao R Huang; Arthur C K Chung; Li Zhou; Xiao J Wang; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2008-01-23       Impact factor: 10.121

7.  Interleukin-17 stimulates the release of pro-inflammatory cytokines by blood monocytes in patients with IgA nephropathy.

Authors:  K Matsumoto; K Kanmatsuse
Journal:  Scand J Urol Nephrol       Date:  2003

Review 8.  Toll-like receptors: emerging concepts in kidney disease.

Authors:  Hans-Joachim Anders; Detlef Schlöndorff
Journal:  Curr Opin Nephrol Hypertens       Date:  2007-05       Impact factor: 2.894

9.  TGF-beta1 and CTGF mRNAs are correlated with urinary protein level in IgA nephropathy.

Authors:  Sachiko Nonaka Takahashi; Takayuki Fujita; Teruyiki Takahashi; Yuki Wada; Yoshinobu Fuke; Atsushi Satomura; Koichi Matsumoto
Journal:  J Nephrol       Date:  2008 Jan-Feb       Impact factor: 3.902

10.  The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor.

Authors:  T Calandra; J Bernhagen; R A Mitchell; R Bucala
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more
  6 in total

1.  The beneficial effects of statin therapy may not apply to all forms of crescentic glomerulonephritis.

Authors:  Bahjat Al-Ani; Hamad Al Nuaimi; Caroline Savage
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  A case of secondary focal segmental glomerulosclerosis associated with malignant hypertension.

Authors:  Kumiko Fukuda; Akira Shimizu; Tomohiro Kaneko; Yukinari Masuda; Fumihiko Yasuda; Megumi Fukui; Seiichiro Higo; Akio Hirama; Akiko Mii; Shuichi Tsuruoka; Ryuji Ohashi; Yasuhiko Iino; Yuh Fukuda; Yasuo Katayama
Journal:  CEN Case Rep       Date:  2012-12-07

3.  Glomerular hemophagocytic macrophages in a patient with proteinuria and clinical and laboratory features of hemophagocytic lymphohistiocytosis (HLH).

Authors:  Ling Cao; William Dean Wallace; Shahrooz Eshaghian; Yuliya Linhares; Victor J Marder
Journal:  Int J Hematol       Date:  2011-11-01       Impact factor: 2.490

4.  Clinicopathological and immunohistological features in childhood IgA nephropathy: a single-centre experience.

Authors:  Rezan Topaloglu; Dicle Orhan; Yelda Bilginer; Erdem Karabulut; Fatih Ozaltin; Ali Duzova; Gulsev Kale; Nesrin Besbas
Journal:  Clin Kidney J       Date:  2013-02-24

5.  Respiratory Syncytial Virus Aggravates Renal Injury through Cytokines and Direct Renal Injury.

Authors:  Songhui Zhai; Lijuan Hu; Lin Zhong; Yannan Guo; Liqun Dong; Ruizhen Jia; Zheng Wang
Journal:  Front Cell Infect Microbiol       Date:  2016-09-30       Impact factor: 5.293

6.  Low intratumor heterogeneity correlates with increased response to PD-1 blockade in renal cell carcinoma.

Authors:  Xia Ran; Jinyuan Xiao; Yi Zhang; Huajing Teng; Fang Cheng; Huiqian Chen; Kaifan Zhang; Zhongsheng Sun
Journal:  Ther Adv Med Oncol       Date:  2020-12-18       Impact factor: 8.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.